Cite
Identification of a pyroptosis‐based model for predicting clinical outcomes from immunotherapy in patients with metastatic melanoma
MLA
Guanghao Wu, et al. “Identification of a Pyroptosis‐based Model for Predicting Clinical Outcomes from Immunotherapy in Patients with Metastatic Melanoma.” Cancer Medicine, vol. 12, Sept. 2022, pp. 4921–37. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8fc38591f5f6b440d3f2e947c584391c&authtype=sso&custid=ns315887.
APA
Guanghao Wu, Biying Chen, Junjie Jiang, Yiran Chen, Yanyan Chen, & Haiyong Wang. (2022). Identification of a pyroptosis‐based model for predicting clinical outcomes from immunotherapy in patients with metastatic melanoma. Cancer Medicine, 12, 4921–4937.
Chicago
Guanghao Wu, Biying Chen, Junjie Jiang, Yiran Chen, Yanyan Chen, and Haiyong Wang. 2022. “Identification of a Pyroptosis‐based Model for Predicting Clinical Outcomes from Immunotherapy in Patients with Metastatic Melanoma.” Cancer Medicine 12 (September): 4921–37. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8fc38591f5f6b440d3f2e947c584391c&authtype=sso&custid=ns315887.